Gonococcal Conjunctivitis

What is Gonococcal Conjunctivitis?

Gonococcal conjunctivitis is an infection of the thin membrane that covers the white part of the eye (the conjunctiva) caused by the bacterium Neisseria gonorrhoeae. It is the ocular manifestation of the sexually transmitted infection (STI) gonorrhea. The disease can affect anyone who is exposed to the bacteria, but it is most common in neonates (known as ophthalmia neonatorum) and adults who have genital or rectal gonorrhea and then transfer the organism to the eye via hand‑to‑eye contact or sexual practices.

Because N. gonorrhoeae produces an aggressive inflammatory response, the infection can progress rapidly to corneal ulceration, perforation, and vision loss if not treated promptly. This urgency makes gonococcal conjunctivitis a medical emergency rather than a routine irritation.

Common Causes

The underlying cause is the presence of N. gonorrhoeae on the ocular surface. Several circumstances increase the likelihood of this happening:

• Neonatal exposure at birth: Infected mother’s vaginal secretions contact the infant’s eyes.
• Direct inoculation from genital secretions: Touching the eye after handling infected genital discharge.
• Unprotected oral‑genital contact: Oral sex with a partner who has gonorrhea can transfer bacteria to the mouth and then to the eyes.
• Autoinoculation from the hands: Rubbing eyes after using the restroom or after sexual activity.
• Use of contaminated eye cosmetics or instruments: Sharing makeup, eye drops, or contact lenses with an infected person.
• Trauma or surgery: Corneal abrasions or procedures that breach the ocular surface can allow bacteria to colonize.
• Systemic gonorrhea infection: In rare cases, bacteremia spreads to the eye.
• Contact lens wear: Improper hygiene can promote bacterial growth, especially if the wearer also has genital gonorrhea.
• Co‑infection with other STIs: Concurrent chlamydia or herpes infections can increase susceptibility to gonococcal eye disease.
• Immunocompromised state: HIV infection or immunosuppressive therapy reduces the body’s ability to contain the bacteria.

Associated Symptoms

Gonococcal conjunctivitis typically produces a striking clinical picture. Common accompanying features include:

• Profuse purulent discharge: Thick, yellow‑green or brown mucus that may cause the eyelids to stick together, especially upon waking.
• Redness (hyperemia): Intense inflammation of the conjunctiva and surrounding sclera.
• Eye pain or burning sensation: May feel gritty or like a foreign body.
• Photophobia: Discomfort or pain when looking at bright light.
• Swelling of the eyelids (blepharitis): Edematous, sometimes tender lids.
• Decreased visual acuity: Blurred vision can develop quickly if the cornea becomes involved.
• Fever and malaise: Systemic signs are more common in neonates or in adults with disseminated gonococcal infection.
• Foreign‑body sensation: The eye may feel like something is stuck in it.
• Rapid progression: Symptoms can worsen within hours, distinguishing it from milder bacterial conjunctivitis.

When to See a Doctor

Because gonococcal conjunctivitis can threaten sight, early medical evaluation is essential. Seek care promptly if you notice any of the following:

• Sudden onset of copious, pus‑filled discharge from one or both eyes.
• Severe eye redness that spreads beyond the conjunctiva.
• Intense eye pain, especially with light exposure.
• Blurry vision or the sensation that vision is worsening.
• Swelling of the eyelids that does not improve with warm compresses.
• Fever, joint pain, or skin lesions that suggest disseminated gonococcal infection.
• For newborns: any eye discharge, swelling, or redness within the first 2 weeks of life.

Delaying treatment increases the risk of corneal ulceration, perforation, and permanent vision loss.

Diagnosis

Diagnosis relies on a combination of clinical suspicion and laboratory confirmation.

Clinical examination

• Slit‑lamp or ophthalmoscopic exam to assess conjunctival hyperemia, corneal involvement, and the amount/type of discharge.
• Evaluation of visual acuity and intra‑ocular pressure.

Laboratory tests

• Gram stain of conjunctival swab: Shows Gram‑negative diplococci inside neutrophils – a classic finding for gonorrhea.
• Culture on selective media (Thayer‑Martin agar): Confirms the organism and allows antimicrobial sensitivity testing.
• Nucleic acid amplification test (NAAT): Highly sensitive and specific; can be performed on ocular swabs, urine, or genital specimens.
• Rapid antigen tests: Less common but may be used in urgent settings.

Additional work‑up

If systemic disease is suspected, clinicians may order blood cultures, joint aspiration, or skin lesion biopsies to rule out disseminated gonococcal infection.

Treatment Options

Immediate treatment with systemic antibiotics is mandatory; topical therapy alone is insufficient.

First‑line systemic therapy

• Ceftriaxone 500 mg intramuscular (IM) in a single dose for adults and adolescents (CDC 2023 guidelines).
• For neonates, the recommended dose is 50 mg/kg IM** once**, or 25 mg/kg every 12 hours for 7 days if signs persist.